TC-1827

TC-1827
Names
	Preferred IUPAC name (2S,4E)-N-Methyl-5-(pyrimidin-5-yl)pent-4-en-2-amine
Identifiers
CAS Number	547741-76-4 ;
3D model (JSmol)	Interactive image;
ChemSpider	8329797;
PubChem CID	10154289;
	InChI InChI=1S/C10H15N3/c1-9(11-2)4-3-5-10-6-12-8-13-7-10/h3,5-9,11H,4H2,1-2H3/b5-3+/t9-/m0/s1 Key: VZNTWLIIJWUCEP-SGRBOOSSSA-N;
	SMILES C[C@H](NC)C/C=C/C1=CN=CN=C1;
Properties
Chemical formula	C10H15N3
Molar mass	177.251 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

TC-1827 is an orally active, selective agonist of the α₄β₂ nicotinic receptors. Administration of TC-1827 improved memory and learning in a variety in rodents, and increased long-term potentiation in hippocampal slices. In addition, the compound was without significant cardiovascular side effects, except for a small, transient rise in arterial blood pressure. The pro-cognitive effects of TC-1827 last much longer than the short half life (0.2 - 1.0 hours) would suggest.[1]

References

Bohme, Georg Andrees (May 2004). "In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity". Drug Development Research. 62 (1): 26–40. doi:10.1002/ddr.10352. S2CID 86072368.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Bohme-1] Bohme, Georg Andrees (May 2004). "In vitro and in vivo characterization of TC-1827, a novel brain α4β2 nicotinic receptor agonist with pro-cognitive activity". Drug Development Research. 62 (1): 26–40. doi:10.1002/ddr.10352. S2CID 86072368.